TB Alliance Case Study on Expanding Access to Life-Saving Tuberculosis Treatments Published by INSEAD
MBA students tackle one of global health’s toughest challenges – how to reduce drug rollout timelines to just one year
Press Releases
Academic Study Finds TB Alliance’s Access Approach Successfully Accelerated Uptake of New TB Treatments
Findings underscore critical role of product development partnerships in delivering both innovation and access GENEVA (April 24, 2026)—A new peer-reviewed
New Report: LIFT-TB Helped Cut Time to Global Uptake of Improved Drug-Resistant TB Treatments from Nearly a Decade to Three Years
Country-led evidence and implementation support enabled faster adoption of shorter, more effective regimens worldwide SEOUL (April 13, 2026)—A new independent
Doris Macharia Elected President of TB Alliance’s Global TB Stakeholders, Joins Board of Directors
Global health leader brings deep expertise in advancing children’s health, HIV, and global health equity NEW YORK (March 2, 2026)—TB
TB Alliance Announces New Collaboration with Novartis to Advance the Research and Development of Telacebec for Leprosy
New collaboration aims to advance innovation for a neglected and stigmatizing disease affecting hundreds of thousands worldwide NEW YORK (January
TB Alliance and Asian Development Bank Forge Strategic Partnership to Strengthen Regional Efforts Against Tuberculosis
New York, USA and Manila, Philippines — [Date] — TB Alliance and the Asian Development Bank (ADB) have announced a
Promising New Data on Pediatric Use of Pretomanid in Children with Drug-Resistant Tuberculosis Presented at 2025 Union Conference
Positive results mark an important step forward in efforts to develop effective treatments for children with drug-resistant TB COPENHAGEN, Denmark
Phase 2 Clinical Trial Results Show Potential to Shorten TB Treatment Time
Thuto Pulane, a TB survivor and participant in the NC-009 trial, at a follow-up appointment with Dr. William Brumskine, NC-009
Realizing our “Triple-A Mandate”
Four years ago, TB Alliance secured the first regulatory approval from the United States Food and Drug Administration (US FDA)
TB Alliance Issues Call for Researchers to Access TB Biomarker Repository
NEW YORK (March 23, 2021) – Interested researchers are invited to apply to access the MARK-TB (Markedly Accelerating Research with